StockWatch
·
Commodity Chemicals
Quarterly Result11 Nov 2026, 02:03 pm

Indo Borax H1FY27 Income Up 16% to ₹129.29 Cr; Acquires Kronox Lab

AI Summary

Indo Borax & Chemicals Ltd reported a 16.0% growth in consolidated operating income for H1FY27 to ₹129.29 crore (₹111.42 crore in H1FY26). However, consolidated Profit After Tax (PAT) for H1FY27 stood at ₹21.00 crore, a decrease from ₹26.47 crore in H1FY26. Adjusted EBITDA for H1FY27 was ₹28.09 crore, up 22.9% from H1FY26. The company completed the acquisition of a 64.26% stake in Kronox Lab Sciences Ltd and appointed a new MD & CEO for Kronox. Additionally, the board approved the amalgamation of its wholly-owned subsidiary, Indoborax Infrastructure Private Ltd, with Indo Borax Chemicals, subject to regulatory approvals. For Q2FY27, consolidated operating income was ₹58.94 crore, with PAT at ₹4.75 crore, impacted by acquisition expenses and higher raw material costs.

Key Highlights

  • H1FY27 consolidated operating income rose 16.0% to ₹129.29 crore.
  • H1FY27 consolidated PAT decreased to ₹21.00 crore from ₹26.47 crore.
  • Acquisition of 64.26% stake in Kronox Lab Sciences Ltd completed.
  • Board approved amalgamation of subsidiary Indoborax Infrastructure.
  • Q2FY27 PAT impacted by acquisition costs and raw material prices.